The outcome for patients with cerebrovascular disease in university and community hospitals.
D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D002533:Cerebral Angiography; D002543:Cerebral Hemorrhage / Q000401:mortality; D002561:Cerebrovascular Disorders / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality* / Q000628:therapy; D002908:Chronic Disease; D004569:Electroencephalography; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006973:Hypertension / Q000401:mortality; D002546:Ischemic Attack, Transient / Q000401:mortality; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D010208:Papaverine / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D011379:Prognosis; D011787:Quality of Health Care; D011877:Radionuclide Imaging; D013345:Subarachnoid Hemorrhage / Q000401:mortality
D000925:Anticoagulants; D010208:Papaverine